Advanced search
Publication Cover
Clinical Epidemiology Volume 11, 2019 - Issue
Submit an article Journal homepage
123
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Treatment intensity and survival in patients with relapsed or refractory diffuse large B-cell lymphoma in Denmark: a real-life population-based study

Bente Arboe1 Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark, [email protected];2 Survivorship, The Danish Cancer Society Research Center, Copenhagen, Denmark, [email protected]Correspondence[email protected]
,
Maja Halgren Olsen2 Survivorship, The Danish Cancer Society Research Center, Copenhagen, Denmark, [email protected]
,
Jette Sønderskov Gørløv1 Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark, [email protected]
,
Anne Katrine Duun-Henriksen3 Statistics and Pharmacoepidemiology, The Danish Cancer Society Research Center, Copenhagen, Denmark
,
Susanne Oksbjerg Dalton2 Survivorship, The Danish Cancer Society Research Center, Copenhagen, Denmark, [email protected];4 Department of Clinical Oncology and Palliative Care Units, Zealand University Hospital, Naestved, Denmark
,
Christoffer Johansen2 Survivorship, The Danish Cancer Society Research Center, Copenhagen, Denmark, [email protected];5 Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark
&
Peter de Nully Brown1 Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark, [email protected]
 show all
Pages 207-216 | Published online: 04 Mar 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Gunn Ammitzbøll, Anne Katrine Graudal Levinsen, Trille Kristina Kjær, Freja Ejlebæk Ebbestad, Trine Allerslev Horsbøl, Lena Saltbæk, Sara Koed Badre-Esfahani, Andrea Joensen, Eva Kjeldsted, Maja Halgren Olsen & Susanne Oksbjerg Dalton. (2022) Socioeconomic inequality in cancer in the Nordic countries. A systematic review. Acta Oncologica 61:11, pages 1317-1331.
Read now
Wei Xie, Meng-Ke Liu, Xu-Feng Jiang, Xiao-Dong Gao, Biao Li, Li Wang & Wei-Li Zhao. (2021) Improved prediction of chemoresistance in patients with diffuse large B-cell lymphoma through a new interim positron emission tomography-computed tomography evaluation model. Acta Oncologica 60:6, pages 735-743.
Read now
Xiao Jun Wang, Yi-Ho Wang, Shing Chau Tony Li, Christina Gkitzia, Soon Thye Lim, Liang Piu Koh, Francesca Lorraine Wei Inng Lim & William Ying Khee Hwang. (2021) Cost-effectiveness and budget impact analyses of tisagenlecleucel in adult patients with relapsed or refractory diffuse large B-cell lymphoma from Singapore’s private insurance payer’s perspective. Journal of Medical Economics 24:1, pages 637-653.
Read now

Articles from other publishers (6)

Leo I. Gordon, Reem Karmali, Jason B. Kaplan, Rakesh Popat, Howard A. BurrisIIIIII, Silvia Ferrari, Sumit Madan, Manish R. Patel, Giuseppe Gritti, Dima El-Sharkawi, F. Ian Chau, John Radford, Jaime Pérez de Oteyza, Pier Luigi Zinzani, Swaminathan P. Iyer, William Townsend, Harry Miao, Igor Proscurshim, Shining Wang, Shilpi Katyayan, Ying Yuan, Jiaxi Zhu, Kate Stumpo, Yaping Shou, Cecilia Carpio & Francesc Bosch. (2023) Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659). Oncotarget 14:1, pages 57-70.
Crossref
Sara Ekberg, Michael Crowther, Sara Harrysson, Mats Jerkeman, Karin E. Smedby & Sandra Eloranta. (2022) Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission. British Journal of Cancer 127:9, pages 1642-1649.
Crossref
Samuli Tuominen, Kristiina Uusi-Rauva, Tea Blom, Sirkku Jyrkkiö, Kaisa Tuppurainen & Erika Alanne. (2022) Real-world data on diffuse large B-cell lymphoma in 2010–2019: usability of large data sets of Finnish hospital data lakes. Future Oncology 18:9, pages 1103-1114.
Crossref
Willem Daneels, Michael Rosskamp, Gilles Macq, Estabraq Ismael Saadoon, Anke De Geyndt, Fritz Offner & Hélène A. Poirel. (2022) Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study. Frontiers in Oncology 12.
Crossref
Reena Nair, Dinesh Bhurani, Senthil Rajappa, Asha Kapadia, Rakesh Reddy Boya, Subramanian Sundaram, Hari Menon, Ganapathi S. Raman, Arun Seshachalam & Ramesh Nimmagadda. (2022) Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the OncoCollect Lymphoma Registry. Frontiers in Oncology 11.
Crossref
Shuo Wang, Li Wang, Jianda Hu, Wenbin Qian, Xi Zhang, Yu Hu, Qi Zhu, Bobin Chen, Depei Wu, Chung‐Chou H. Chang, Pengpeng Xu, Xiaoyun Zheng, Juying Wei, Yao Liu, Guohui Cui, Yong Tang, Yan Ma, Haiwen Huang, Hongmei Yi & Weili Zhao. (2021) Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China. Cancer Communications 41:3, pages 229-239.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.